Sec Form 4 Filing - GALLIKER STEPHEN S @ Galena Biopharma, Inc. - 2014-02-03

Insider filing report for Changes in Beneficial Ownership
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
FORM 4
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Expires: November 30, 2011
Estimated average burden hours per response... 0.5
1. Name and Address of Reporting Person
GALLIKER STEPHEN S
2. Issuer Name and Ticker or Trading Symbol
Galena Biopharma, Inc. [ GALE]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X __ Director _____ 10% Owner
_____ Officer (give title below) _____ Other (specify below)
(Last) (First) (Middle)
4640 SW MACADAM AVE., SUITE 270
3. Date of Earliest Transaction (MM/DD/YY)
02/03/2014
(Street)
PORTLAND, OR97239
4. If Amendment, Date Original Filed (MM/DD/YY)
6. Individual or Joint/Group Filing (Check Applicable Line)
__ X __ Form filed by One Reporting Person
_____ Form filed by More than One Reporting Person
(City) (State) (Zip)
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3)
2. Transaction Date (MM/DD/YY) 2A. Deemed Execution Date, if any (MM/DD/YY) 3. Transaction Code
(Instr. 8)
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)
6. Ownership Form: Direct (D) or Indirect (I)
(Instr. 4)
7. Nature of Indirect Beneficial Ownership
(Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 02/03/2014 M 50,000 A $ 2.31 60,000 D
Common Stock 02/03/2014 M 100,000 A $ 1.18 160,000 D
Common Stock 02/03/2014 M 50,000 A $ 0.85 210,000 D
Common Stock 02/03/2014 M 50,000 A $ 0.72 260,000 D
Common Stock 02/03/2014 M 50,000 A $ 1.71 310,000 D
Common Stock 02/03/2014 S 300,000 D $ 4.1768 ( 1 ) 10,000 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
( e.g. , puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security
(Instr. 3)
2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (MM/DD/YY) 3A. Deemed Execution Date, if any (MM/DD/YY) 4. Transaction Code
(Instr. 8)
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4, and 5)
6. Date Exercisable and Expiration Date
(MM/DD/YY)
7. Title and Amount of Underlying Securities
(Instr. 3 and 4)
8. Price of Derivative Security
(Instr. 5)
9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 4)
10. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 4)
11. Nature of Indirect Beneficial Ownership
(Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Option (right to buy) $ 2.31 02/03/2014 M 50,000 ( 2 ) 01/13/2021 Common Stock 50,000 $ 0 0 D
Stock Option (right to buy) $ 1.18 02/03/2014 M 100,000 ( 3 ) 03/24/2021 Common Stock 100,000 $ 0 0 D
Stock Option (right to buy) $ 0.85 02/03/2014 M 50,000 09/27/2011 09/27/2021 Common Stock 50,000 $ 0 0 D
Stock Option (right to buy) $ 0.72 02/03/2014 M 50,000 ( 4 ) 01/12/2022 Common Stock 50,000 $ 0 0 D
Stock Option (right to buy) $ 1.71 02/03/2014 M 50,000 ( 5 ) 01/29/2023 Common Stock 50,000 $ 0 0 D
Reporting Owners
Reporting Owner Name / Address Relationships
Director 10% Owner Officer Other
GALLIKER STEPHEN S
4640 SW MACADAM AVE., SUITE 270
PORTLAND, OR97239
X
Signatures
/s/ Stephen S. Galliker 02/05/2014
Signature of Reporting Person Date
Explanation of Responses:
( 1 )The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.16 to $4.47 per share. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
( 2 )The option vested in equal quarterly installments of 12,500 on each of March 31, 2011, June 30, 2011, September 30, 2011 and December 31, 2011.
( 3 )The option vested in equal quarterly installments of 25,000 on each of June 25, 2011, September 25, 2011, December 25, 2011 and March 25, 2012.
( 4 )The option vested in equal quarterly installments of 12,500 on each of April 12, 2012, July 12, 2012, October 12, 2012 and January 12, 2013.
( 5 )The option vested in equal quarterly installments of 12,500 on each of April 29, 2013, July 29, 2013, October 29, 2013 and January 29, 2014.

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.